发明名称 Heparin/heparan sulfate-dependent inhibitors of activated protein C and uses thereof in treating hemophilic disorders
摘要 Methods for inhibiting activated protein C (APC) comprising contacting the APC with a Kunitz polypeptide in an amount effective in inhibiting the activity of APC, wherein the Kunitz polypeptide comprises six cysteine residues at positions corresponding to positions 7, 16, 32, 40, 53, and 57 in SEQ ID NO:1, a motif X1GX2CBX′ at positions corresponding to positions 13-18 in SEQ ID NO:1, wherein each of X1 and X2, independently, is any amino acid residue, B is a basic amino acid residue, and X′ is G, A, or V; and at least one heparin-binding motif, which can present at the C-terminus of the Kunitz polypeptide.
申请公布号 US9206246(B2) 申请公布日期 2015.12.08
申请号 US201314081427 申请日期 2013.11.15
申请人 Academia Sinica 发明人 Tsai Inn-Ho;Cheng An-Chun
分类号 A61K38/00;C07K14/00;C07K14/81;C07K14/46 主分类号 A61K38/00
代理机构 Wolf, Greenfield & Sacks, P.C. 代理人 Wolf, Greenfield & Sacks, P.C.
主权项 1. A method for inhibiting activated protein C (APC), comprising contacting the APC with a Kunitz polypeptide in an amount effective in inhibiting the activity of APC,wherein: the Kunitz polypeptide comprises the amino acid sequence of SEQ ID NO:1.
地址 Taipei TW